Sanara Medtech INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Sanara MedTech Inc. has filed a Schedule 13G amendment indicating zero beneficial ownership for reporting persons Tall Pines Capital, LLC and Stonebridge Wealth Management, LLC.
NASDAQ
Baird Trust Company, Baird Financial Corporation, and Baird Financial Group, Inc. have collectively reported beneficial ownership of 21,075 shares of Sanara MedTech Inc. common stock.
NASDAQ
Baird Trust Company and its affiliates have reported a beneficial ownership of 8.5% in Sanara MedTech Inc. common stock as of December 31, 2025.